Enriqueta Felip
0000-0002-7620-0098
Publication & Citation Trends
Publications
0 total
Datopotamab Deruxtecan Plus Pembrolizumab With or Without Platinum-Based Chemotherapy for Advanced or Metastatic NSCLC: The Phase Ib TROPION-Lung02 Trial.
Cited by 0
Semantic Scholar
A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
Cited by 0
Semantic Scholar
1368TiP EPROPA: The European program for routine testing of patients with advanced lung cancer OA
Cited by 0
Semantic Scholar
MA21.03 The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer OA
Cited by 1
Semantic Scholar
OA01.09 Comparing Regional Results from the IASLC Global Survey on Molecular Testing in Lung Cancer OA
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(905)
Cancer Immunotherapy and Biomarkers
(405)
Lung Cancer Research Studies
(394)
Lung Cancer Diagnosis and Treatment
(268)
Cancer Genomics and Diagnostics
(220)
Affiliations
Université Paris-Sud
Universitat de Vic - Universitat Central de Catalunya
Roche (Switzerland)
Institució Catalana de Recerca i Estudis Avançats
Hebron University